Current Value of Holding

$480k

Shares

829k

% of Portfolio

0.00%

Average Buy Price

$2.05

Avg closing price
Price range

12 Ken Griffin Neumora Therapeutics Trades

Ken Griffin acquired 829k Neumora Therapeutics shares worth $480k. That's 0.00% of their equity portfolio (3973rd largest holding). The first Neumora Therapeutics trade was made in Q3 2023. Since then Ken Griffin bought shares four more times and sold shares on seven occasions. The investor's estimated purchase price is $1.7M, resulting in a loss of 72%.

Avg closing price
Price range
Increased shares by 141.3% (+485k shares) Q2 2026
Avg closing price $1.90
Price range $1.46 - $2.47
Sold 32.1% shares (-162k shares) Q1 2026
Avg closing price $2.48
Price range $1.64 - $3.59
New holding (+506k shares) Q4 2025
Avg closing price $2.19
Price range $1.71 - $3.02
Sold -17.2k shares Q3 2025
Avg closing price $1.61
Price range $0.78 - $2.35
New holding (+17.2k shares) Q2 2025
Avg closing price $0.76
Price range $0.62 - $1.09
Sold -145k shares Q1 2025
Avg closing price $1.73
Price range $1.00 - $2.58
Increased shares by 206712.9% (+145k shares) Q4 2024
Avg closing price $11.93
Price range $9.66 - $16.96
Sold 100.0% shares (-860k shares) Q3 2024
Avg closing price $11.63
Price range $9.76 - $13.21
Sold 52.8% shares (-964k shares) Q2 2024
Avg closing price $10.35
Price range $8.60 - $14.70
Sold 1.0% shares (-19.3k shares) Q1 2024
Avg closing price $16.17
Price range $12.44 - $19.76
Sold 15.0% shares (-325k shares) Q4 2023
Avg closing price $12.27
Price range $9.64 - $17.90
New holding (+2.17M shares) Q3 2023
Avg closing price $12.50
Price range $10.13 - $16.25

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!